STRUCTURAL FEATURES OF PLATELET ACTIVATING FACTOR (1-ALKYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE) REQUIRED FOR HYPOTENSIVE AND PLATELET SEROTONIN RESPONSES
- 1 January 1982
- journal article
- research article
- Vol. 38 (1) , 3-20
Abstract
A number of analogs similar in structure to biologically active 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) were tested for their relative effectiveness in lowering the blood pressure of spontaneous hypertensive rats and in releasing [3H]serotonin from rabbit platelets. Except for some minor variations, the 2 test systems gave the same pattern of relative responses for a given analog. Both biological activities (the antihypertensive response and release of platelet serotonin) appear to be stereospecific since the unnatural isomer exhibited no detectable effects. Other structural modifications that greatly reduced (> 500-fold) or eliminated the 2 biological activities were removal of the acetate group, substitution of the acetate group with long-chain acyl, methoxy, benzoxy, N-formyl, N-trifluoroacetyl, N-hexadecanoyl or deoxy groups such as dimethyl, propyl, isopropyl or isobutyl and replacement of the sn-l O-alkyl group with an acyl moiety. Biological activities were reduced to a lesser extent (100- to 500-fold) when the sn-2 C contained butyrate or hexanoate groups or if ethanolamine was substituted for the choline base. Replacing the sn-2 acetate group with an ethoxy group lowered the activity 48- and 120-fold for the blood pressure and serotonin release, respectively. Substitution of propionate for acetate at the sn-2 C gave a compound that was at least, if not more, biologically active than the parent structure; although an N-acetyl analog possessed biologic activities, the responses were only 0.27-1.0% of those obtained with the O-acetyl lipid. Maximum biological activity for both hypotensive effects and platelet serotonin release required a glycerolipid having an alkyl ether at the sn-l, acetate or propionate groups at the sn-2, and phosphocholine at the sn-3 positions.This publication has 22 references indexed in Scilit:
- Human neutrophil-derived platelet activating factor.The Journal of Immunology, 1980
- Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).Journal of Biological Chemistry, 1979
- Antihypertensive activity of an alkyl ether analog of phosphatidylcholineBiochemical and Biophysical Research Communications, 1979
- Biosynthesis of plasmalogens by the microsomal fraction of Fischer R-3259 sarcoma. Influence of specific 2-acyl chains on the desaturation of 1-alkyl-2-acyl-sn-glycero-3-phosphoethanolamineBiochemistry, 1979
- EFFECT OF LYSOLECITHIN AND ANALOGS ON MOUSE ASCITES TUMORS1978
- Characterization of the alkyl ether species of phosphatidylcholine in bovine heartJournal of Lipid Research, 1977
- Glycerophospholipid synthesis: improved general method and new analogs containing photoactivable groups.Proceedings of the National Academy of Sciences, 1977
- Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response.The Journal of Experimental Medicine, 1976
- Chromatographic separation of plasmalogenic, alkyl-acyl, and diacyl forms of ethanolamine glycerophosphatidesJournal of Lipid Research, 1967
- Transphosphatidylation by Phospholipase DJournal of Biological Chemistry, 1967